48 results on '"Kocka, Viktor"'
Search Results
2. Absorb Bioresorbable Scaffold Versus Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis: Rationale and Design of the COMPARE ABSORB Trial
3. Optical coherence tomography in STEMI with bioresorbable scaffold: possible cause of coronary flow impairment? A sub-study from the Prague 19 trial
4. Czech TAVI registry – Hospital outcome
5. The coronary angiography – An old-timer in great shape
6. Cardiac Etiology of Exercise Induced Hypoxemia within Elite Athletes: 3176 Board #222 May 31 3:30 PM - 5:00 PM
7. Absorb Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Metallic Stent in ST-Segment Elevation Myocardial Infarction: 1-Year Results of a Propensity Score Matching Comparison: The BVS-EXAMINATION Study (Bioresorbable Vascular Scaffold-A Clinical Evaluation of Everolimus Eluting Coronary Stents in the Treatment of Patients With ST-segment Elevation Myocardial Infarction)
8. A pilot randomised trial of catheter-directed thrombolysis or standard anticoagulation for patients with intermediate-high risk acute pulmonary embolism
9. Long-term follow-up in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention
10. LONG-TERM OUTCOME IN PATIENTS AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION - CAN WE RISK-STRATIFY?
11. Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX
12. Lack of association between clopidogrel responsiveness tested using point-of-care assay and prognosis of patients with coronary artery disease
13. High leukocyte count and interleukin-10 predict high on-treatment-platelet-reactivity in patients treated with clopidogrel
14. Modified Strategies for Invasive Management of Acute Coronary Syndrome during the COVID-19 Pandemic
15. TCT CONNECT-249 Real-World Dual Antiplatelet Therapy Following Polymer-free, Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease
16. Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE-ABSORB randomised clinical trial
17. Cardiac resynchronization therapy implantation following transcatheter aortic valve implantation
18. Bioresorbable vascular scaffolds versus everolimus-eluting metallic stents in patients with ST-segment elevation myocardial infarction: 5-year results of the BVS-EXAMINATION study
19. Cardiac resynchronization therapy for the causal treatment of heart failure with preserved ejection fraction: insight from a pressure–volume loop analysis
20. TCT-166 Optimal Vessel Sizing for the Bioresorbable Scaffold Implantation and the Incidence of Scaffold Thrombosis: Insights From the COMPARE-ABSORB Trial
21. Ibutilide-Induced Cardioversion of Atrial Fibrillation During Pregnancy
22. Mortality prediction after transcatheter treatment of failed bioprosthetic aortic valves utilizing various international scoring systems: Insights from the Valve-in-Valve International Data (VIVID)
23. Relationship between TRAIL and Left Ventricular Ejection Fraction in Patients with ST-Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention
24. Takotsubo Cardiomyopathy: One More Angiographic Evidence of Microvascular Dysfunction
25. TCT-728 Polymer-free sirolimus eluting stents in a large scale all comers population
26. OCT findings of radiotherapy-induced coronary artery disease: A “two-hit combined hypothesis”
27. Potential role of invariant natural killer T cells in outcomes of acute myocardial infarction
28. Spatially Organized Structure of Coronary Thrombus in Acute Myocardial Infarction
29. TCT-404 ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-year results from a propensity score matched comparison
30. ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-Year results from a propensity score matched comparison
31. Invasive Hemodynamic Assessment of Cardiac Output State after MitraClip Therapy in Nonanaesthetized Patients with Functional Mitral Regurgitation
32. One-Year Clinical and Computed Tomography Angiographic Outcomes After Bioresorbable Vascular Scaffold Implantation During Primary Percutaneous Coronary Intervention for ST-Segment–Elevation Myocardial Infarction
33. Abstract 13551: Invasive Hemodynamic Assessment of Cardiac Output State After MitraClip Therapy
34. Right subclavian approach in transcatheter aortic valve implantation using the CoreValve prosthesis
35. Transcatheter aortic valve implantation: long-term clinical outcome and valve durability
36. How should I treat subacute stent thrombosis in the context of brain haemorrhage with abciximab?
37. Platelet-derived chemokines, PF-4 and RANTES, are significantly increased in hemodynamically significant degenerative aortic stenosis
38. Two-year follow-up after bioresorbable vascular scaffold implantation in STEMI patients — Results from PRAGUE-19 study
39. Pharmacodynamic Effect of Clopidogrel in Patients Undergoing Transcatheter Aortic Valve Implantation
40. Lack of association between clopidogrel responsiveness tested using point-of-care assay and prognosis of patients with coronary artery disease
41. Abstract 396: Serum Osteoprotegerin (OPG) Differs Significantly in Patients with Calcified Aortic Valve Stenosis in Relation to the Presence of Coronary Atherosclerosis
42. High leukocyte count and interleukin-10 predict high on-treatment-platelet-reactivity in patients treated with clopidogrel
43. Clopidogrel up-titration versus standard dose in patients with high residual platelet reactivity after percutaneous coronary intervention: A single-center pilot randomised study
44. Five year two center retrospective analysis of patients with toxic digoxin serum concentration
45. Heart Failure With Preserved Ejection Fraction in Outpatients With Unexplained Dyspnea
46. Predictors of Improvement of Unrepaired Moderate Ischemic Mitral Regurgitation in Patients Undergoing Elective Isolated Coronary Artery Bypass Graft Surgery
47. Heart Failure With Preserved Ejection Fraction in Outpatients With Unexplained Dyspnea A Pressure-Volume Loop Analysis
48. Bioresorbable vascular scaffolds in STEMI patients: multimodality imaging comparison in mid-term perspective.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.